SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-035010
Filing Date
2021-03-11
Accepted
2021-03-11 16:15:44
Documents
8
Period of Report
2021-03-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm219251d1_8k.htm 8-K 26603
2 EXHIBIT 4.1 tm219251d1_ex4-1.htm EX-4.1 51538
3 EXHIBIT 10.1 tm219251d1_ex10-1.htm EX-10.1 74522
4 EXHIBIT 99.1 tm219251d1_ex99-1.htm EX-99.1 12447
5 GRAPHIC tm219251d1_ex4-1img001.jpg GRAPHIC 1450
6 GRAPHIC tm219251d1_ex4-1img002.jpg GRAPHIC 1525
7 GRAPHIC tm219251d1_ex99-1img002.jpg GRAPHIC 3075
8 GRAPHIC tm219251d1_ex99-1img003.jpg GRAPHIC 3075
  Complete submission text file 0001104659-21-035010.txt   179787
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 21733477
SIC: 2834 Pharmaceutical Preparations